AwardTape · Defense awards · Medical · Drugs and biologicals · HSHQDC15D00016
HSHQDC15D00016: $0 IDIQ contract to Glaxosmithkline, LLC
Glaxosmithkline, LLC holds an IDIQ contract from Office of Procurement Operations with $0 obligated since Oct 2023, against a ceiling of $26.4M. Latest action Jun 20, 2025.
Igf::ot::igf acquisition of relenza for DHS antiviral stockpile
| PIID | HSHQDC15D00016 |
|---|---|
| Type | IDIQ contract |
| Company | Glaxosmithkline, LLC |
| Agency | Office of Procurement Operations |
| Contracting office | DEPARTMENTAL OPERATIONS ACQUISITION DIVISION I |
| Category | Medical · Drugs and biologicals |
| PSC | 6505 DRUGS AND BIOLOGICALS |
| NAICS | 325412 PHARMACEUTICAL PREPARATION MANUFACTURING |
| Obligated since Oct 2023 | $0 |
| Total obligated (lifetime) | $0 |
| Ceiling (base and all options) | $26.4M |
| Base date | Jul 10, 2015 |
| Latest action | Jun 20, 2025 |
| End date | n/a |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Not competed |
| Source | USAspending.gov record |
| Reporting lag | Civilian, days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial